Old Web
English
Sign In
Acemap
>
authorDetail
>
Chaim M. Brickman
Chaim M. Brickman
Medicine
Internal medicine
Cardiology
Immunology
Randomized controlled trial
6
Papers
118
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
VDA-1102 : A Novel Well-Tolerated Treatment For Actinic Keratosis
2018
Chaim M. Brickman
Vered Behar
Galit Zelinger
Oren M. Becker
Show All
Source
Cite
Save
Citations (1)
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial
2009
Journal of Thrombosis and Thrombolysis
David A. Morrow
Chaim M. Brickman
Sabina A. Murphy
Kenneth W. Baran
Ricardo Krakover
Harold L. Dauerman
Sujatha Kumar
Natanya Slomowitz
Laura T. Grip
Carolyn H. McCabe
Andrew L Salzman
Show All
Source
Cite
Save
Citations (60)
Nimesulide-induced hepatitis and acute liver failure.
1999
Israel Medical Association Journal
Peretz Weiss
Meir Mouallem
Rafael Bruck
David Hassin
Amir Tanay
Chaim M. Brickman
Zvi Farfel
Simon Bar–Meir
Show All
Source
Cite
Save
Citations (31)
The Phenotype of SLE Associated with Complete Deficiency of Complement Isotype C4A
1998
Journal of Clinical Immunology
Thomas R. Welch
Chaim M. Brickman
Nancy Bishof
Silvio Maringhini
Mark Rutkowski
Marie Frenzke
Nancy L. Kantor
Show All
Source
Cite
Save
Citations (26)
A new, simplified method for oxidation of human complement component C2.
1990
Journal of Immunological Methods
Chaim M. Brickman
James P. Atherton
Nancy L. Kantor
Show All
Source
Cite
Save
Citations (0)
1